Cephalexin

Product NDC
70518-4511
Requested package NDC
70518-4511-0
11-digit product format
705184511
Labeler code
70518
Product ID
70518-4511_5b870337-c133-dd79-e063-6394a90a03ef
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cephalexin
Dosage form
FOR SUSPENSION
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA210221
Marketing category
ANDA
Marketing start
2025-10-28
Substance
CEPHALEXIN
Active strength
250 mg/5mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210221-001CEPHALEXINCEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26
A210221-002CEPHALEXINCEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A210221-001AB
A210221-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26c2088c7a36db…
2026-10-15 13:18:302026-09A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26c2088c7a36db…
2026-09-14 22:38:342026-08A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2684e616aacf4f…
2026-09-14 22:38:342026-08A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2684e616aacf4f…
2026-08-18 06:07:402026-07A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26caaa826d4ba7…
2026-08-18 06:07:402026-07A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2631067a03dcf5…
2025-08-23 18:47 UTC2025-08A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-266a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-262680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-265bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-265bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26d06236e962d9…
2024-10-29 15:01 UTC2024-10A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2679d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-2679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-26301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-261e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-261e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-268072bd15b7f6…
2024-05-31 18:47 UTC2024-05A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-268072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-265c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-265c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-265d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-265d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210221-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-264b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A210221-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2019-03-264b0b4de00fa7…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09A210221-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A210221-002AB1c2088c7a36db…
2026-09-14 22:38:342026-08A210221-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A210221-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A210221-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A210221-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210221-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210221-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210221-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210221-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A210221-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210221-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210221-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210221-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210221-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210221-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210221-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210221-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210221-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210221-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210221-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210221-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210221-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210221-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210221-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A210221-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210221-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210221-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210221-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210221-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210221-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210221-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210221-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A210221-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210221-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210221-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210221-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A210221-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210221-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A210221-002AB14b0b4de00fa7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Cephalexin
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEPHALEXIN250 mg/5mL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dfa3f520-409c-432e-b6d3-9250d468c772Product name120250401
64bb7f1a-2c2e-4741-8301-dbfeda7239f6Product name120190628
398aa563-bb78-fe0f-46a8-757c40ef28bfProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-4511-0Cephalexin100 mL in 1 BOTTLEFOR SUSPENSION1001

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 19 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CephalexinCEPHALEXINBryant Ranch Prepack06c2fb2e-0539-4f16-bac4-e15a575ca8022026-04-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINPreferred Pharmaceuticlas Inc.fbf5fcdf-40fc-40e5-b784-308032fff0e52026-03-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINPreferred Pharmaceuticals, Inc.6c7bfa58-2d38-4607-8c33-485ba4931c682026-03-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.ee278959-d321-d356-e053-2995a90a32c22026-01-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepackc7028200-b141-496b-89e9-491558d4c8792025-11-10Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepack5f867aa3-ea64-4a14-a63b-979b8ff8d80c2025-11-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepack8d7f247a-3b42-4823-96fb-5f5c1bd94d492025-08-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepack1bfa8744-24ee-4c70-845c-c532b80844332025-07-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepacka8f14231-5d43-46f7-ba1f-d6de8162d5e72024-11-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepacke186afb5-7531-45ea-b785-c230483a77472024-08-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepackf1439d25-3d3d-4fe5-b6e7-d76e628929692024-08-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINA-S Medication Solutions28fec572-e3b9-448c-8626-5c0920f38eeb2024-07-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepackdf6bb893-e3d7-4c8f-8cec-35b4d2fa33b32024-07-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepackf4ced8c7-a276-4a44-a60c-f8d1689a2bdf2024-07-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.ada33464-b416-9ac6-e053-2a95a90af7872024-07-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.90a76d24-e5a9-9000-e053-2a95a90ae8af2024-06-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINBryant Ranch Prepack92be9844-0775-4808-bdeb-dccb09647d912024-03-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINA-S Medication Solutions0edeb103-5e94-4f42-828f-c7336486c7842024-02-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221
CephalexinCEPHALEXINAscend Laboratories, LLCbb28751c-bd1b-4e7f-8271-a14c1b4314e32022-07-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210221
application number: ANDA210221

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309113cephalexin 250 MG in 5 mL Oral SuspensionPSN9fc5cfb0-7ba0-4669-b79c-270b6a9ff5731
309113cephalexin 50 MG/ML Oral SuspensionSCD9fc5cfb0-7ba0-4669-b79c-270b6a9ff5731
309113cefalexin 50 MG/ML Oral SuspensionSY9fc5cfb0-7ba0-4669-b79c-270b6a9ff5731
309113cephalexin 250 MG per 5 ML Oral SuspensionSY9fc5cfb0-7ba0-4669-b79c-270b6a9ff5731

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70518-4511-070518451100100 mL in 1 BOTTLE (70518-4511-0) 100 ml2025-10-28NoNoCurrent